Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients

Journal of Nephrology

Volumn 14, Issue 4, 2001, Pages 293-298

  Zoccali, C ^a   Mallamaci, F ^a   Asahia, K ^a   Benedetto, F A ^a   Tripepi, G ^a   Tripepi, R ^a   Nicocia, G ^a   Buemi, M ^a   Miyata, T ^a  

^a CNR   (Italy)

Author keywords

Advanced glycation end products; Carbonyl stress; Dialysis; LVH; Pentosidine; Uremia

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; IMMUNOGLOBULIN G; PENTOSIDINE;

ADULT; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CAROTID ARTERY; DIALYSIS; DISEASE MARKER; DOPPLER ECHOCARDIOGRAPHY; DRUG BLOOD LEVEL; ECHOCARDIOGRAPHY; FEMALE; GEOMETRY; GLYCATION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE WALL; HEMODIALYSIS PATIENT; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROTEIN BLOOD LEVEL; THICKNESS; UREMIA;

ARGININE; CAROTID ARTERY DISEASES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEART VENTRICLES; HUMANS; KIDNEY FAILURE, CHRONIC; LYSINE; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0034903144     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. On the epidemic of cardiovascular disease in patients with chronic renal disease and progressive renal failure: A first step to improve the outcomes
2. Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start?
3. Cardiovascular risk in uremic patients: Is it fully explained by classical risk factors?
4. Uremic intoxication
5. Middle molecules: Toxicity and removal by hemodialysis and related strategies
6. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine
7. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: Carbonyl stress in uremia
8. Advanced glycation and products: A nephrologist's perspective
9. Ultrasound in clinical trials in atherosclerosis
10. Noninvasive quantification of atherosclerotic lessions. Reproducibility of ultrasonographic measurements of arterial wall thickness and plaque size
11. The renin-angiotensin-aldosterone system and carotid artery disease in mild-to-moderate primary hypertension
12. The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography. Results of a survey of echocardiographic measurements
13. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
14. The spectrum of left ventricular hypertrophy in a general population sample: The Framingham study
15. Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients
16. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients
17. Alterations in non-enzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications
18. Monocyte / macrophage response to beta 2-microglobulin modified with advanced glycation end products
19. Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1
20. Advanced glycosylation end products in patients with diabetic nephropathy
21. 2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: Role of glycoxidation and lipoxidation reactions in vascular tissue damage
22. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease
23. Cardiac structure and function in renal disease
24. Cardiac disease in chronic uremia: Pathogenesis
25. Effects of glucose intolerance on myocardial function and collagen-linked glycation
26. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress"